Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Goeddel David V
Relationship:   10% Owner
City:   So. San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   9    
Direct Shares   21,008,913    

Indirect Shares

   32,725,451      
Direct Value   $107,224,205    

Indirect Value

   $145,808,454      
Total Shares   53,734,364      
Total Value   $253,032,660      


Immune Design Corp. $0 Gritstone Oncology, Inc. $2,316,030 Rapt Therapeutics, Inc. $22,803,513 Oric Pharmaceuticals, Inc. $0 Revolution Medicines, Inc. $82,104,662 Nurix Therapeutics, Inc. $0 Immune Design Corp. $0 Gritstone Oncology, Inc. $2,316,030 Rapt Therapeutics, Inc. $22,803,513 Oric Pharmaceuticals, Inc. $0 Revolution Medicines, Inc. $82,104,662 Nurix Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    63   
    4    

     Stock price went up :
    24   
    1    
     Stock price went down :
    39   
    3    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   -0.2%
 -73.3%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Immune Design Corp. IMDZ 10% Owner 2016-09-20 3,961,942 2014-07-29 0    Premium*  
            Gritstone Oncology, Inc. GRTS Managing Partner 2018-10-02 3,102,934 2018-10-02 0    Premium*  
            Ngm Biopharmaceuticals Inc NGM Director, 10% Owner 2024-04-05 0 2024-04-05 1,000    Premium*  
            Rapt Therapeutics, Inc. RAPT Managing Partner, 10% ... 2020-09-22 5,630,497 2019-11-04 195,401    Premium*  
            Oric Pharmaceuticals, Inc. ORIC Managing Partner, 10% ... 2020-04-28 4,768,181 0    Premium*  
            Revolution Medicines, Inc. RVMD 10% Owner 2020-11-16 2,151,026 2020-11-16 3,799,202    Premium*  
            Nurix Therapeutics, Inc. NRIX 10% Owner 2021-05-05 1,394,333 2021-05-05 1,420,954    Premium*  
            Tenaya Therapeutics, Inc. TNYA 2021-08-03 0 2024-02-12 22,999,565    Premium*  
            Effector Therapeutics Ord Shs EFTR 10% Owner 0 2021-08-25 4,309,329    Premium*  
* Premium Members only  

Records found :    145         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-10-23 4 B $11.86 $24,752 I/I 2,087 16,602,405 2.17 -
RAPT Rapt Therapeutics, Inc. Director   –       •       •   2019-10-30 3 IO $0.00 $0 I/I 0 50,000 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-11-04 4 B $11.99 $100,824 I/I 8,409 16,610,814 2.25 -
RAPT Rapt Therapeutics, Inc. Director   –       •       •   2019-11-04 4 A $0.00 $0 I/I 6,102,151 145,401 0 -
RAPT Rapt Therapeutics, Inc. Director   –       •       •   2019-11-04 4 B $12.00 $7,500,000 I/I 625,000 4,982,333 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-11-11 4 B $12.00 $180 I/I 15 16,610,829 2.17 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-02-06 4 B $15.96 $716,604 I/I 44,900 16,655,729 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-02-26 4 B $18.00 $67,518 I/I 3,751 16,659,480 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-02-27 4 B $17.91 $607,077 I/I 33,896 16,693,376 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-02-28 4 B $17.91 $676,998 I/I 37,800 16,731,176 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-02 4 B $17.90 $252,820 I/I 14,124 16,745,300 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-03 4 B $17.99 $697,256 I/I 38,758 16,784,058 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-04 4 B $17.96 $179,349 I/I 9,986 16,794,044 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-05 4 B $18.00 $149,526 I/I 8,307 16,802,351 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-19 4 B $11.59 $1,720,698 I/I 148,464 16,950,815 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-20 4 B $11.77 $1,684,075 I/I 143,082 17,093,897 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-23 4 B $11.63 $1,981,601 I/I 170,387 17,264,284 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-24 4 B $12.22 $1,568,767 I/I 128,377 17,392,661 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-25 4 B $12.49 $30,176 I/I 2,416 17,395,077 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-31 4 B $12.53 $1,479,380 I/I 118,067 17,513,144 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-04-01 4 B $12.26 $1,447,501 I/I 118,067 17,631,211 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-04-02 4 B $12.40 $184,140 I/I 14,850 17,646,061 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-04-03 4 B $12.41 $181,025 I/I 14,587 17,660,648 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-04-07 4 B $14.38 $1,779,209 I/I 123,728 17,784,376 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-04-08 4 B $14.95 $1,683,400 I/I 112,602 17,896,978 2.25 %
  145  Records found
  1   2   3  4   5   6      
  Page 3 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us